The states are considered highest risk because the estimator shows they would have an inadequate supply of respiratory therapists under any COVID-19 demand scenario and no workforce attrition.
Projections from the estimator are based on an April 21 update of Institute for Health Metrics and Evaluation COVID-19 Hospitalization Data, as well as American Hospital Association 2018 survey data, using only short-term acute hospitals. They assume hospitals are adopting surge capacity staffing ratios and don’t account for respiratory therapist staffing distribution at different locations and healthcare organizations within a state.
More information about the methodology is available here.
Here are supply and demand estimates for New York, New Jersey and Connecticut under the mean COVID-19 demand scenario and no workforce attrition.
New York
Respiratory therapist supply: 4,490
Shortage for adequate COVID-19 response: 7,400
New Jersey
Respiratory therapist supply: 1,857
Shortage for adequate COVID-19 response: 3,745
Connecticut
Respiratory therapist supply: 704
Shortage for adequate COVID-19 response: 1,409
Read more about the estimator here.
More articles on workforce:
Envision deploys, reassigns more than 500 clinicians to fight coronavirus
US releases COVID-19 healthcare workforce toolkit
7 Medical City Healthcare hospitals open mini grocery stores for workers
